Cite
HARVARD Citation
Ahn, S. et al. (2016). A phase 3b study of sofosbuvir plus ribavirin in treatment‐naive and treatment‐experienced Korean patients chronically infected with genotype 2 hepatitis C virus. Journal of viral hepatitis. 23 (5), pp. 358-365. [Online].